Celine Dion Sings Publicly For First Time In 4 Years In Sweet Backstage Video At The Grammys

Music icon Celine Dion wowed social media users after she was filmed singing backstage at the 2024 Grammy Awards with singer-songwriter Sonyae Elise, marking the first time she's sung in public since she canceled her 2020 world tour due to stiff person syndrome.

Elise, a Platinum Hit winner, took to Instagram to share a behind-the-scenes clip from the awards ceremony, capturing the unforgettable experience of singing with the singer best known for hits like "My Heart Will Go On" and "The Power of Love."

In the video, Dion showcases her incredible vocals while Elise joins in beside her. Elise captioned the montage clip on Instagram, calling it the "Highlights of an ICONIC night" and expressing her inspiration and pride in being a part of such a memorable event.

You can see the video below.

It also went viral on X, formerly Twitter.

The Grammys also saw Dion make a surprise appearance, despite her ongoing battle with stiff-person syndrome (SPS), a rare neurological disorder. Dion presented the Album of the Year award to Taylor Swift for Midnights, marking Swift's fourth win in that category.

Dion's return to the stage follows her confirmation of the SPS diagnosis in December 2022. The rare disorder is characterized by stiff muscles, increased sensitivity to stimuli, and, over time, potential hunched-over postures. Despite the challenges posed by SPS, Dion's public return at the Grammys was met with enthusiasm from fans.

Many applauded the iconic singer and were just happy to see her doing what she does best—perform.

Dion's appearance at the Grammys came days after announcing the upcoming release of her documentary, "I Am: Céline Dion," set to stream on Amazon Prime Video.

Directed by Oscar-nominated documentarian Irene Taylor, the film promises an intimate look into Dion's life post-SPS diagnosis, offering fans a deeper understanding of the singer's health journey.

Dion's diagnosis has helped raise more public awareness around SPS, which is expected to affect one or two people per million, according to Johns Hopkins Medicine.